« Previous
Next »
Journal of Renal Nutrition
Volume 16, Issue 3
, Pages 245-247
, July 2006
L-Arginine: A New Opportunity in the Management of Clinical Derangements in Dialysis Patients
References
- . Role of arginine in health and in renal disease . Am J Physiol . 1994;267:F331–F346
- . Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine . Pharmacol Res . 2004;49:397–414
- . Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the “L-arginine paradox” and acts as a novel cardiovascular risk factor . J Nutr . 2004;134:2842S–2847S
- Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients . J Clin Invest . 2000;105:1217–1225
- L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats . J Am Soc Nephrol . 1993;4:1039–1045
- Arginase inhibition slows the progression of renal failure in rats with renal ablation . Am J Physiol Renal Physiol . 2003;284:F680–F687
- Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries . Am J Cardiol . 2004;93:933–935
- Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure . Kidney Int . 1999;56:674–684
- . L-arginine and hypertension . J Nutr . 2004;134:2807S–2811S discussion 2818S-2819S
- Effect of oral L-arginine on oxidant stress, endothelial dysfunction, and systemic arterial pressure in young cardiac transplant recipients . Am J Cardiol . 2004;94:828–831
PII: S1051-2276(06)00084-7
doi: 10.1053/j.jrn.2006.04.004
© 2006 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
Journal of Renal Nutrition
Volume 16, Issue 3
, Pages 245-247
, July 2006

